Acute effects of novel selenazolidines on murine chemoprotective enzymes

Chemico-Biological Interactions

Volumn 162, Issue 1, 2006, Pages 31-42

  El Sayed, Wael M ^a   Aboul Fadl, Tarek ^a   Lamb, John G ^a   Roberts, Jeanette C ^b   Franklin, Michael R ^a  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Glutathione peroxidase; Glutathione transferases; Microsomal epoxide hydrolase; Mouse; mRNA; NAD(P)H quinone oxidoreductase; Selenazolidines; Selenium; Selenocysteine prodrugs; Thioredoxin reductase; UDP glucuronosyltransferases

Indexed keywords

GLUCURONOSYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 1A1; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; MESSENGER RNA; MICROSOME ENZYME; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SELENAZOLE DERIVATIVE; SELENOCYSTINE; THIOREDOXIN REDUCTASE;

ANIMAL CELL; ARTICLE; CALCULATION; CANCER; CANCER PREVENTION; CORRELATION ANALYSIS; DRUG EFFECT; ENZYME BLOOD LEVEL; GENETIC TRANSCRIPTION; MALE; MOUSE; NONHUMAN;

ALANINE TRANSAMINASE; ANIMALS; BIOLOGICAL MARKERS; CYTOPROTECTION; ENZYMES; EPOXIDE HYDROLASES; GLUCURONOSYLTRANSFERASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; LIVER; MALE; MICE; PRODRUGS; RNA, MESSENGER; SELENOCYSTEINE; TIME FACTORS;

MURINAE;

EID: 33746048439     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2006.05.002     Document Type: Article

References (58)

1. Nayini J., El-Bayoumy K., Sugie S., Cohen L.A., and Reddy B.S. Chemoprevention of experimental mammary carcinogenesis by the synthetic organoselenium compound, benzylselenocyanate, in rats. Carcinogenesis 10 (1989) 509-512
2. El-Bayoumy K., Upadhyaya P., Desai D.H., Amin S., and Hecht S.S. Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone tumorigenicity in mouse lung by the synthetic organoselenium compound, 1,4-phenylenebis(methylene)selenocyanate. Carcinogenesis 6 (1993) 1111-1113
3. Li L., Xie Y., El-Sayed W.M., Szakacs J.G., Franklin M.R., and Roberts J.C. Chemopreventive activity of selenocysteine prodrugs against tobacco-derived nitrosamine (NNK) induced lung tumors in the A/J mouse. J. Biochem. Mol. Toxicol. 19 (2005) 396-405
4. Curphey T.J., Kuhlmann E.T., Roebuck B.D., and Longnecker D.S. Inhibition of pancreatic and liver carcinogenesis in rats by retinoid- and selenium-supplemented diets. Pancreas 3 (1988) 36-40
5. Lane H.W., Teer P., Dukes J., Johnson J., and White M.T. The effect of four chemical forms of selenium on mammary tumor incidence in BALB/c female mice treated with 7-12-dimethylbenz[a]anthracene. Cancer Lett. 50 (1990) 39-44
6. Ip C. Factors influencing the anticarcinogenic efficacy of selenium in dimethylbenz[a]anthracene-induced mammary tumorigenesis in rats. Cancer Res. 41 (1981) 2683-2686
7. Ip C. Prophylaxis of mammary neoplasia by selenium supplementation in the initiation and promotion phases of chemical carcinogenesis. Cancer Res. 41 (1981) 4386-4390
8. Ip C., and Sinha D. Anticarcinogenic effect of selenium in rats treated with dimethylbenz[a]anthracene and fed different levels and types of fat. Carcinogenesis 2 (1981) 435-438
9. Ip C., and White G. Mammary cancer chemoprevention by inorganic and organic selenium: single agent treatment or in combination with Vitamin E and their effects on in vitro immune functions. Carcinogenesis 8 (1987) 1763-1766
10. Ip C., Hayes C., Budnick R.M., and Ganther H.E. Chemical form of selenium, critical metabolites, and cancer prevention. Cancer Res. 51 (1991) 595-600
11. Ip C., and Ganther H.E. Comparison of selenium and sulfur analogs in cancer prevention. Carcinogenesis 13 (1992) 1167-1170
12. Ip C., Zhu Z., Thompson H.J., Lisk D., and Ganther H.E. Chemoprevention of mammary cancer with Se-allylselenocysteine and other selenoamino acids in the rat. Anticancer Res. 19 (1999) 2875-2880
13. El-Bayoumy K. Effects of organoselenium compounds on induction of mouse forestomach tumors by benzo(a)pyrene. Cancer Res. 45 (1985) 3631-3635
14. Sugie S., Reddy B.S., El-Bayoumy K., and Tanaka T. Inhibition by dietary benzylselenocyanate of hepatocarcinogenesis induced by azoxymethane in Fischer 344 rats. Jpn. J. Cancer Res. 80 (1989) 952-957
15. Reddy B.S., Rivenson A., Kulkarni N., Upadhyaya P., and El-Bayoumy K. Chemoprevention of colon carcinogenesis by the synthetic organoselenium compound, 1,4-phenylenebis(methylene) selenocyanate. Cancer Res. 52 (1992) 5635-5640
16. El-Bayoumy K., Chae Y.H., Upadhyaya P., Meschter C., Cohen L.A., and Reddy B.S. Inhibition of 7,12-dimethylbenz(a)anthracene-induced tumors and DNA adduct formation in the mammary glands of female Sprague-Dawley rats by the synthetic organoselenium compound, 1,4-phenylenebis(methylene)selenocyanate. Cancer Res. 52 (1992) 2402-2407
17. El-Bayoumy K., Upadhyaya P., Desai D.H., Amin S., Hoffmann D., and Wynder E.L. Effects of 1,4-phenylenebis(methylene)selenocyanate, phenethyl isothiocyanate, indole-3-carbinol, and d-limonene individually and in combination on the tumorigenicity of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung. Anticancer Res. 16 (1996) 2709-2712
18. Prokopczyk B., Amin S., Desai D.H., Kurtzke C., Upadhyaya P., and El-Bayoumy K. Effects of 1,4-phenylenebis(methylene)selenocyanate and selenomethionine on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorigenesis in A/J mouse lung. Carcinogenesis 18 (1997) 1855-1857
19. Prokopczyk B., Rosa J.G., Desai D., Amin S., Sohn O.S., Fiala E.S., and El-Bayoumy K. Chemoprevention of lung tumorigenesis induced by a mixture of benzo(a)pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by the organoselenium compound 1,4-phenylenebis(methylene)selenocyanate. Cancer Lett. 161 (2000) 35-46
20. Das A., Desai D., Pittman B., Amin S., and El-Bayoumy K. Comparison of the chemopreventive efficacies of 1,4-phenylenebis(methylene)selenocyanate and selenium-enriched yeast on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced lung tumorigenesis in A/J mouse. Nutr. Cancer 46 (2003) 179-185
21. Tanaka T., Makita H., Kawabata K., Mori H., and El-Bayoumy K. 1,4-Phenylenebis(methylene) selenocyanate exerts exceptional chemopreventive activity in rat tongue carcinogenesis. Cancer Res. 57 (1997) 3644-3648
22. Rao C.V., Cooma I., Rodriguez J.G., Simi B., El-Bayoumy K., and Reddy B.S. Chemoprevention of familial adenomatous polyposis development in the APC(min) mouse model by 1,4-phenylene bis(methylene)selenocyanate. Carcinogenesis 21 (2000) 617-621
23. Rao C.V., Wang C.Q., Simi B., Rodriguez J.G., Cooma I., El-Bayoumy K., and Reddy B.S. Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity. Cancer Res. 61 (2001) 3647-3652
24. Ip C., Vadhanavikit S., and Ganther H.E. Cancer chemoprevention by aliphatic selenocyanates: effect of chain length on inhibition of mammary tumors and DMBA adducts. Carcinogenesis 16 (1995) 35-38
25. Ip C., Lisk D.J., and Ganther H.E. Activities of structurally-related lipophilic selenium compounds as cancer chemopreventive agents. Anticancer Res. 18 (1998) 4019-4025
26. Ip C., Lisk D.J., Ganther H.E., and Thompson H.J. Triphenylselenonium and diphenylselenide in cancer chemoprevention: comparative studies of anticarcinogenic efficacy, tissue selenium levels and excretion profile. Anticancer Res. 17 (1997) 3195-3199
27. Ip C., Thompson H.J., Zhu Z., and Ganther H.E. In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention. Cancer Res. 60 (2000) 2882-2886
28. Tanaka T., Reddy B.S., and El-Bayoumy K. Inhibition by dietary organoselenium, p-methoxybenzene-selenol, of hepatocarcinogenesis induced by azoxymethane in rats. Jpn. J. Cancer Res. 76 (1985) 462-467
29. Das R.K., and Bhattacharya S. Anti-tumour promoting activity of diphenylmethyl selenocyanate against two-stage mouse skin carcinogenesis. Asian Pacific J. Cancer Prev. 6 (2005) 181-188
30. Ghosh S., Das R.K., Sengupta A., and Bhattacharya S. Inhibition of azoxymethane-induced aberrant crypt foci in rat by diphenylmethyl selenocyanate through downregulation of COX-2 and modulation of glutathione transferase and lipid peroxidation. Biol. Trace Elem. Res. 105 (2005) 171-185
31. Kawamori T., El-Bayoumy K., Ji B.Y., Rodriguez J.G., Rao C.V., and Reddy B.S. Evaluation of benzyl selenocyanate glutathione conjugate for potential chemopreventive properties in colon carcinogenesis. Int. J. Oncol. 13 (1998) 29-34
32. Sohn O.S., Fiala E.S., Upadhyaya P., Chae Y.H., and El-Bayoumy K. Comparative effects of phenylenebis(methylene)selenocyanate isomers on xenobiotic metabolizing enzymes in organs of female CD rats. Carcinogenesis 20 (1999) 615-621
33. Ganther H.E., and Ip C. Thioredoxin reductase activity in rat liver is not affected by supranutritional levels of monomethylated selenium in vivo and is inhibited only by high levels of selenium in vitro. J. Nutr. 131 (2001) 301-304
34. Xie Y., Short M.D., Cassidy P.B., and Roberts J.C. Selenazolidines as novel organoselenium delivery agents. Bioorg. Med. Chem. Lett. 11 (2001) 2911-2915
35. Short M.D., Xie Y., Li L., Cassidy P.D., and Roberts J.C. Characteristics of selenazolidine prodrugs of selenocysteine: toxicity and glutathione peroxidase induction in V79 cells. J. Med. Chem. 46 (2003) 3308-3313
36. Wroblewski F., and LaDue J.S. Serum glutamic pyruvic transaminase in cardiac with hepatic disease. Proc. Soc. Exp. Biol. Med. 91 (1956) 569-571
37. Le H.T., Lamb J.G., and Franklin M.R. Drug metabolizing enzyme induction by benzoquinolines, acridine, and quinacrine; tricyclic aromatic molecules containing a single heterocyclic nitrogen. J. Biochem. Toxicol. 11 (1996) 297-303
38. El-Sayed W.M., Aboul-Fadl T., Lamb J.G., Roberts J.C., and Franklin M.R. Effect of selenium-containing compounds on hepatic chemoprotective enzymes in mice. Toxicology 220 (2006) 179-188
39. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
40. Habig W.H., and Jakoby W.B. Glutathione S-transferases (rat and human). Meth. Enzymol. 77 (1981) 218-231
41. Lamb J.G., and Franklin M.R. Early events in the induction of rat hepatic UDP-glucuronosyltransferases, glutathione S-transferase, and microsomal epoxide hydrolase by 1,7-phenanthroline: comparison with oltipraz, tert-butyl-4-hydroxyanisole, and tert-butylhydroquinone. Drug Metab. Dispos. 28 (2000) 1018-1023
42. Christensen M.J., and Burgener K.W. Dietary selenium stabilizes glutathione peroxidase mRNA in rat liver. J. Nutr. 122 (1992) 1620-1626
43. Hill K.E., Lyons P.R., and Burk R.F. Differential regulation of rat liver selenoprotein mRNAs in selenium deficiency. Biochem. Biophys. Res. Commun. 185 (1992) 260-263
44. Bermano G., Nicol F., Dyer J.A., Sunde R.A., Beckett G.J., Arthur J.R., and Hesketh J.E. Tissue-specific regulation of selenoenzyme gene expression during selenium deficiency in rats. Biochem. J. 311 (1995) 425-430
45. Weiss-Sachdev S., and Sunde R.A. Selenium regulation of transcript abundance and translational efficiency of glutathione peroxidase-1 and -4 in rat liver. Biochem. J. 357 (2001) 851-858
46. Hadley K.B., and Sunde R.A. Selenium regulation of thioredoxin reductase activity and mRNA levels in rat liver. J. Nutr. Biochem. 12 (2001) 693-702
47. Hintze K.J., Wald K.A., Zeng H., Jeffery E.H., and Finley J.W. Thioredoxin reductase in human hepatoma cells is transcriptionally regulated by sulforaphane and other electrophiles via an antioxidant response element. J. Nutr. 133 (2003) 2721-2727
48. Zhang J., Svehlikova V., Bao Y., Howie A.F., Beckett G.J., and Williamson G. Synergy between sulforaphane and selenium in the induction of thioredoxin reductase 1 requires both transcriptional and translational modulation. Carcinogenesis 24 (2003) 497-503
49. Gallegos A., Berggren M., Gasdaska J.R., and Powis G. Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium. Cancer Res. 57 (1997) 4965-4970
50. Gan L., Liu Q., Xu H.B., Zhu Y.S., and Yang X.L. Effects of selenium overexposure on glutathione peroxidase and thioredoxin reductase gene expressions and activities. Biol. Trace Elem. Res. 89 (2002) 165-175
51. Hoen P.A.'t., Rooseboom M., Bijsterbosch M.K., van Berkel T.J., and Vermeulen J.N. Commandeur, Induction of glutathione S-transferase mRNA levels by chemopreventive selenocysteine Se-conjugates. Biochem. Pharmacol. 63 (2002) 1843-1849
52. El-Bayoumy K., Narayanan B.A., Desai D.H., Narayanan N.K., Pittman B., Amin S.G., Schwartz J., and Nixon D.W. Elucidation of molecular targets of mammary cancer chemoprevention in the rat by organoselenium compounds using cDNA microarray. Carcinogenesis 24 (2003) 1505-1514
53. Chang M., Burgess J.R., Scholz R.W., and Reddy C.C. The induction of specific rat liver glutathione S-transferase subunits under inadequate selenium nutrition causes an increase in prostaglandin F2 alpha formation. J. Biol. Chem. 265 (1990) 5418-5423
54. Favreau L.V., and Pickett C.B. Transcriptional regulation of the rat NAD(P)H:quinone reductase gene. Characterization of a DNA-protein interaction at the antioxidant responsive element and induction by 12-O-tetradecanoylphorbol 13-acetate. J. Biol. Chem. 268 (1993) 19875-19881
55. Watson W.H., Pohl J., Montfort W.R., Stuchlik O., Reed M.S., Powis G., and Jones D.P. Redox potential of human thioredoxin 1 and identification of a second dithiol/disulfide motif. J. Biol. Chem. 278 (2003) 33408-33415
56. Daniel V., Sharon R., and Bensimon A. Regulatory elements controlling the basal and drug-inducible expression of glutathione S-transferase Ya subunit gene. DNA 8 (1989) 399-408
57. Friling R.S., Bensimon A., Tichauer Y., and Daniel V. Xenobiotic-inducible expression of murine glutathione S-transferase Ya subunit gene is controlled by an electrophile-responsive element. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 6258-6262
58. Rushmore T.H., and Pickett C.B. Transcriptional regulation of the rat glutathione S-transferase Ya subunit gene. Characterization of a xenobiotic-responsive element controlling inducible expression by phenolic antioxidants. J. Biol. Chem. 265 (1990) 14648-14653